Eukaryotic initiation factor 4A (eIF4A) during viral infections

被引:0
|
作者
Hilda Montero
Gustavo Pérez-Gil
Clara L. Sampieri
机构
[1] Universidad Veracruzana,Instituto de Salud Pública
[2] Universidad Veracruzana,Centro de Ciencias Biomédicas
来源
Virus Genes | 2019年 / 55卷
关键词
eIF4A; Translation; Virus; Initiation;
D O I
暂无
中图分类号
学科分类号
摘要
The helicase eIF4A is part of the cellular eIF4F translation initiation complex. The main functions of eIF4A are to remove secondary complex structures within the 5′-untranslated region and to displace proteins attached to mRNA. As intracellular parasites, viruses regulate the processes involved in protein synthesis, and different mechanisms related to controlling translation factors, such as eIF4A, have been found. The inhibitors of this factor are currently known; these substances could be used in the near future as part of antiviral pharmacological therapies in instances of replication cycles in which eIF4A is required. In this review, the particularities of how some viruses make use of this initiation factor to synthesize their proteins are discussed.
引用
收藏
页码:267 / 273
页数:6
相关论文
共 50 条
  • [31] Free initiation factors eIF4A and eIF4B are dispensable for translation initiation on uncapped mRNAs
    P. A. Sakharov
    S. Ch. Agalarov
    Biochemistry (Moscow), 2016, 81 : 1198 - 1204
  • [32] Free initiation factors eIF4A and eIF4B are dispensable for translation initiation on uncapped mRNAs
    Sakharov, P. A.
    Agalarov, S. Ch.
    BIOCHEMISTRY-MOSCOW, 2016, 81 (10) : 1198 - 1204
  • [33] Therapeutic targeting of eukaryotic initiation factor (eIF) 4E
    Pelletier, Jerry
    Sonenberg, Nahum
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2023, 51 (01) : 113 - 124
  • [34] PHOSPHORYLATION OF EUKARYOTIC INITIATION-FACTOR EIF-4E
    RYCHLIK, W
    LAWSON, TG
    HAGEDORN, CH
    THACH, RE
    RHOADS, RE
    FEDERATION PROCEEDINGS, 1987, 46 (06) : 2185 - 2185
  • [35] Interactions of the eukaryotic translation initiation factor eIF4E
    Gross, JD
    Matsuo, H
    Fletcher, M
    Sachs, AB
    Wagner, G
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 2001, 66 : 397 - 402
  • [36] DEVELOPMENT OF NOVEL ANTICANCER AGENTS THAT TARGET PROHIBITINS AND THE TRANSLATION INITIATION FACTOR EIF4A
    Desaubry, L.
    Zhao, Q.
    Basmadjian, C.
    Thuaud, F.
    Ribeiro, N.
    Nebigil, C.
    Eggermont, A.
    Robert, C.
    Vagner, S.
    ANNALS OF ONCOLOGY, 2015, 26
  • [37] Human Translation Initiation Factor eIF4G1 Possesses a Low-Affinity ATP Binding Site Facing the ATP-Binding Cleft of eIF4A in the eIF4G/eIF4A Complex
    Akabayov, Sabine R.
    Akabayov, Barak
    Wagner, Gerhard
    BIOCHEMISTRY, 2014, 53 (41) : 6422 - 6425
  • [38] Mutational analysis of a conserved residue in eukaryotic translation initiation factor 4A
    Shah, Grishma K.
    Patel, Krishna S.
    Low, Woon-Kai
    FASEB JOURNAL, 2011, 25
  • [39] Modifying chemotherapy response by targeted inhibition of eukaryotic initiation factor 4A
    R Cencic
    F Robert
    G Galicia-Vázquez
    A Malina
    K Ravindar
    R Somaiah
    P Pierre
    J Tanaka
    P Deslongchamps
    J Pelletier
    Blood Cancer Journal, 2013, 3 : e128 - e128
  • [40] Modifying chemotherapy response by targeted inhibition of eukaryotic initiation factor 4A
    Cencic, R.
    Robert, F.
    Galicia-Vazquez, G.
    Malina, A.
    Ravindar, K.
    Somaiah, R.
    Pierre, P.
    Tanaka, J.
    Deslongchamps, P.
    Pelletier, J.
    BLOOD CANCER JOURNAL, 2013, 3 : e128 - e128